Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-06588-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

Pre-Clinical Activity of Targeting the PI3K/Akt/mTOR Pathway in Burkitt Lymphoma

Oncotarget
Oncology
2018English

Linc01014 Regulates Gefitinib Resistance in Oesophagus Cancer via EGFR‐PI3K‐AKT‐mTOR Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Necessity to Evaluate PI3K/Akt Signalling Pathway in Proarrhythmia

Open Heart
Cardiovascular MedicineCardiology
2017English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy